Bukwang Pharm Cash Flow Conversion Efficiency

Latest as of September 2025: -0.018x

Bukwang Pharm cash flow conversion efficiency. Based on the latest financial reports, Bukwang Pharm (003000) has a cash flow conversion efficiency ratio of -0.018x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-6.24 Billion ≈ $-4.23 Million USD) by net assets (₩340.83 Billion ≈ $230.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Bukwang Pharm (2007–2024)

Cash flow conversion efficiency of Bukwang Pharm from 2007 to 2024. This chart illustrates how Bukwang Pharm's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Bukwang Pharm stock quote for real-time trading data and today's change.

Bukwang Pharm Cash Flow Conversion Ratio Explained

Bukwang Pharm cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Bukwang Pharm Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bukwang Pharm ranked by their cash flow conversion efficiency. Also see Bukwang Pharm market cap and net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Terrestrial Energy Inc NASDAQ:IMSR	-0.020x
Sichuan Tianwei Electronic Co Ltd SHG:688511	-0.013x
AbClon Inc KQ:174900	-0.114x
Motech Industries Co Ltd TWO:6244	0.132x
Honest Company Inc NASDAQ:HNST	-0.003x
Launch One Acquisition Corp. Unit NASDAQ:LPAAU	-0.002x
Zhubo Design SHE:300564	-0.028x
Creotech Quantum SA WAR:CRQ	N/A

Annual Cash Flow Conversion Efficiency for Bukwang Pharm (2007–2024)

The table below shows the annual cash flow conversion efficiency of Bukwang Pharm from 2007 to 2024. Review free cash flow generation of Bukwang Pharm to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩244.15 Billion ≈ $165.45 Million	₩34.36 Billion ≈ $23.29 Million	0.141x	+452.19%
2023-12-31	₩234.26 Billion ≈ $158.76 Million	₩-9.36 Billion ≈ $-6.34 Million	-0.040x	-165.99%
2022-12-31	₩271.85 Billion ≈ $184.23 Million	₩16.46 Billion ≈ $11.16 Million	0.061x	-36.06%
2021-12-31	₩280.06 Billion ≈ $189.79 Million	₩26.52 Billion ≈ $17.98 Million	0.095x	+3451.72%
2020-12-31	₩271.19 Billion ≈ $183.78 Million	₩723.17 Million ≈ $490.08K	0.003x	+103.72%
2019-12-31	₩326.49 Billion ≈ $221.25 Million	₩-23.41 Billion ≈ $-15.86 Million	-0.072x	-534.85%
2018-12-31	₩413.44 Billion ≈ $280.18 Million	₩6.82 Billion ≈ $4.62 Million	0.016x	-59.31%
2017-12-31	₩211.30 Billion ≈ $143.20 Million	₩8.56 Billion ≈ $5.80 Million	0.041x	+212.04%
2016-12-31	₩214.63 Billion ≈ $145.45 Million	₩-7.76 Billion ≈ $-5.26 Million	-0.036x	-179.08%
2015-12-31	₩225.15 Billion ≈ $152.58 Million	₩10.30 Billion ≈ $6.98 Million	0.046x	-65.53%
2014-12-31	₩210.00 Billion ≈ $142.31 Million	₩27.86 Billion ≈ $18.88 Million	0.133x	-26.94%
2013-12-31	₩201.07 Billion ≈ $136.26 Million	₩36.52 Billion ≈ $24.75 Million	0.182x	+11.16%
2007-12-31	₩170.63 Billion ≈ $115.63 Million	₩27.87 Billion ≈ $18.89 Million	0.163x	--

About Bukwang Pharm

KO:003000 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$247.06 Million

₩364.57 Billion KRW

Market Cap Rank

#15492 Global

#526 in Korea

Share Price

₩3695.00

Change (1 day)

+0.68%

52-Week Range

₩3640.00 - ₩9600.00

All Time High

₩36947.85